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Introduc6on	  
Scopolamine	   is	   a	   tropane	   alkaloid	   extensively	   used	   for	   clinical	   purposes	   because	   is	   a	   selec)ve	   muscarinic	   receptor	   antagonist	  
occurring	  naturally	   in	   solanaceous	   family	  plants,	   such	  as	  Solanium	  dulcamara	   and	  Datura	   stramonium1.	   It	   acts	   like	  a	   compe))ve	  
antagonist	  of	  acetylcholine	  at	  muscarinic	  receptors.	  It	  has	  hallucinogenic	  proper)es	  to	  create	  altered	  states	  at	  the	  Central	  Nervous	  
System	  (CNS)1.	  
Burundanga	  is	  a	  mixture	  of	  scopolamine	  and	  others	  CNS	  depressants.	  It	  is	  related	  with	  various	  types	  of	  poisonings2.	  	  




Is	   an	   an)cholinergic	   compe))ve	  
antagonist	   of	   acetylcholine	   because	  
usually	   contains	   in	   its	   chemical	  
structure	  basic	  and	  steric	  groups	   in	  the	  
same	  propor)on	  that	  acetylcholine.	  
Its	  most	  frequent	  eﬀects	  are3:	  
	  
Ø  Mydriasis	  and	  cycloplegia	  
	  
Ø  Dry	   mouth	   by	   reduc)on	   of	   saliva	  
secre)ons	  
Ø  Overdose:	  An)cholinergic	  syndrome	  
Ø  CNS	   and	   ves)bular	   eﬀects:	   The	  
recommended	  doses	  of	  scopolamine	  
produce	  CNS	  depressive	  eﬀects	  such	  
as	   drowsiness,	   amnesia	   and	   fa)ga.	  
Higher	   doses	   can	   lead	   to	   CNS	  
s)mula)on3.	  
Administra6on	  routes	  
Ø  Tradi6onal	   routes:	   Oral	   tablets	   or	  
parenteral	   injec)ons	   are	   the	  
tradi)onal	   modes	   of	   scopolamine	  
administra)on4.	   This	   leads	   to	  
variable	   drug	   serum	   concentra)ons	  
à	   A	   lot	   of	   limita)ons	   (dose-­‐
dependent	   adverse	   eﬀects	   and	   a	  
short	  half-­‐life	  in	  plasma)3.	  	  
Ø  Transdermal	   therapeu6c	   System	  
(TTS-­‐S	  !	  Fig2)3	   :	  Provide	  a	  constant	  
rate	   of	   delivery	   of	   scopolamine	  
through	  intact	  skin4.	  
Discussion	  
TTS-­‐S	  was	   designed	   to	  maintain	   greater	   control	   of	   drug	   plasma	   concentra)ons	   and	   thereby	   to	   restrict	   the	   incidence	   of	   adverse	  
eﬀects.	  Scopolamine	  tends	  to	  be	  more	  potent	  in	  its	  ac)on	  on	  the	  irirs,	  ciliary	  body	  and	  certain	  secretory	  glands.	  
Scopolamine	  also	  has	  prominent	  CNS	  eﬀects,	  presumably	  due	  to	  the	  greater	  permea)on	  through	  the	  blood-­‐brain	  barrier.	  This	  may	  
be	  the	  basis	  for	  the	  eﬃcacy	  of	  scopolamine	  in	  the	  treatment	  of	  mo)on	  sickness.	  
Burundanga:	  Burundanga	   is	  considered	  an	  emergent	  drug	  which	   is	  used	  under	  criminal	  purposes.	   It	   is	   thought	   that	   this	  drug	  has	  
arrived	  to	  Europe,	  causing	  a	  social	  state	  alatm	  due	  to	  the	  ignorance	  of	  its	  actual	  power.	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Fig1.	  Datura	  stramonium	  	  
Fig	  2.	  Schema)c	  representa)on	  of	  the	  transdermal	  delivery	  
system	  for	  scopolamine	  placed	  on	  the	  skin	  surface3.	  
Fig	   3.	   Scopolamine	   excre)on	   rates	   aqer	   and	   mul)ple	  
applica)ons	   of	   transdermal	   therapeu)c	   system	   for	  
scopolamine	  	  (TTS-­‐S)	  for	  24	  hours3.	  
BURUNDANGA	  
Composi6on:	   Its	   main	   component	   is	  
scopolamine2.	  It	  is	  combined	  with:	  
	  
Ø  Phenothiazines:	   Anxioly)c	   eﬀect.	   Help	   to	  
calm	   down	   the	   vic)m	   and	   causes	  
drowsiness5.	  
Ø  Benzodiazepines:	   An)cholinergic	   eﬀect	  





Burundanga	  has	  immediate	  eﬀects2.	  Aqer	  only	  
2	   to	   5	   minutes	   aqer	   its	   administra)on,	   the	  
vic)m	  is	  under	  its	  eﬀects5.	  
	  
Cascade	   eﬀect:	   The	   drug	   disappears	   but	   its	  
eﬀects	   can	   persist	   on	   the	   brain	   (sequel	   may	  
occur	  à	  That	  may	  lead	  to	  death5.	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